n-acetylcysteinamide has been researched along with Electron Transport Chain Deficiencies, Mitochondrial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bindoff, LA; Chen, A; Glover, JC; Ievglevskyi, O; Kondratskaya, E; Kristiansen, CK; Liang, KX; Sullivan, GJ; Vatne, GH | 1 |
1 other study(ies) available for n-acetylcysteinamide and Electron Transport Chain Deficiencies, Mitochondrial
| Article | Year |
|---|---|
N-acetylcysteine amide ameliorates mitochondrial dysfunction and reduces oxidative stress in hiPSC-derived dopaminergic neurons with POLG mutation.
Topics: Acetylcysteine; Action Potentials; Antioxidants; Cellular Senescence; DNA Polymerase gamma; DNA, Mitochondrial; Dopaminergic Neurons; Electron Transport Complex I; Excitatory Postsynaptic Potentials; Humans; Induced Pluripotent Stem Cells; Membrane Potential, Mitochondrial; Mitochondrial Diseases; Oxidative Stress; Sodium Channels | 2021 |